INTERPACE BIOSCIENCES, INC. Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Interpace Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Interpace Biosciences, Inc. Return On Equity for the quarter ending June 30, 2024 was -4.59 %, a 119% decline year-over-year.
  • Interpace Biosciences, Inc. annual Return On Equity for 2023 was -1.29 %, a 103% decline from 2022.
  • Interpace Biosciences, Inc. annual Return On Equity for 2022 was 40.5 %, a 1.43% increase from 2021.
  • Interpace Biosciences, Inc. annual Return On Equity for 2021 was 39.9 %, a 70.6% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -4.59 -29 -119% Apr 1, 2024 Jun 30, 2024
Q1 2024 -1.48 -34.4 -105% Jan 1, 2024 Mar 31, 2024
Q4 2023 -1.29 -41.8 -103% Oct 1, 2023 Dec 31, 2023
Q3 2023 2.64 -46.5 -94.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 24.5 -6.64 -21.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 32.9 +0.72 +2.24% Jan 1, 2023 Mar 31, 2023
Q4 2022 40.5 +0.57 +1.43% Oct 1, 2022 Dec 31, 2022
Q3 2022 49.2 -7.6 -13.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 31.1 -42.6 -57.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 32.2 -64.5 -66.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 39.9 -95.9 -70.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 56.8 -161 -73.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 73.7 -400 -84.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 96.8 +3.09K Jan 1, 2021 Mar 31, 2021
Q4 2020 136 +457 Oct 1, 2020 Dec 31, 2020
Q3 2020 217 +371 Jul 1, 2020 Sep 30, 2020
Q2 2020 474 +571 Apr 1, 2020 Jun 30, 2020
Q1 2020 -2.99K -2.92K -4241% Jan 1, 2020 Mar 31, 2020
Q4 2019 -321 -257 -396% Oct 1, 2019 Dec 31, 2019
Q3 2019 -153 -207 -383% Jul 1, 2019 Sep 30, 2019
Q2 2019 -97.4 -150 -286% Apr 1, 2019 Jun 30, 2019
Q1 2019 -68.9 -102 -310% Jan 1, 2019 Mar 31, 2019
Q4 2018 -64.9 -137 -190% Oct 1, 2018 Dec 31, 2018
Q3 2018 54.1 +199 Jul 1, 2018 Sep 30, 2018
Q2 2018 52.4 +688 Apr 1, 2018 Jun 30, 2018
Q1 2018 32.8 -888 -96.4% Jan 1, 2018 Mar 31, 2018
Q4 2017 72 -878 -92.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -145 +304 +67.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 -635 -445 -234% Apr 1, 2017 Jun 30, 2017
Q1 2017 921 +1.14K Jan 1, 2017 Mar 31, 2017
Q4 2016 950 +1.1K Oct 1, 2016 Dec 31, 2016
Q3 2016 -449 -229 -104% Jul 1, 2016 Sep 30, 2016
Q2 2016 -190 -46.3 -32.1% Apr 1, 2016 Jun 30, 2016
Q1 2016 -215 -126 -142% Jan 1, 2016 Mar 31, 2016
Q4 2015 -147 -83.7 -132% Oct 1, 2015 Dec 31, 2015
Q3 2015 -220 -179 -427% Jul 1, 2015 Sep 30, 2015
Q2 2015 -144 -113 -362% Apr 1, 2015 Jun 30, 2015
Q1 2015 -88.6 -64.4 -267% Jan 1, 2015 Mar 31, 2015
Q4 2014 -63.6 -51 -402% Oct 1, 2014 Dec 31, 2014
Q3 2014 -41.8 +25.3 +37.7% Jul 1, 2014 Sep 30, 2014
Q2 2014 -31.2 +24.1 +43.6% Apr 1, 2014 Jun 30, 2014
Q1 2014 -24.2 +23.9 +49.8% Jan 1, 2014 Mar 31, 2014
Q4 2013 -12.7 +35 +73.4% Oct 1, 2013 Dec 31, 2013
Q3 2013 -67.1 -46.9 -233% Jul 1, 2013 Sep 30, 2013
Q2 2013 -55.3 -37.3 -207% Apr 1, 2013 Jun 30, 2013
Q1 2013 -48.1 -30 -166% Jan 1, 2013 Mar 31, 2013
Q4 2012 -47.7 Oct 1, 2012 Dec 31, 2012
Q3 2012 -20.2 Jul 1, 2012 Sep 30, 2012
Q2 2012 -18 Apr 1, 2012 Jun 30, 2012
Q1 2012 -18 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.